Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2016

01-11-2016 | Editorial

The Child–Turcotte Classification: From Gestalt to Sophisticated Statistics and Back

Author: Guadalupe Garcia-Tsao

Published in: Digestive Diseases and Sciences | Issue 11/2016

Login to get access

Excerpt

In a landmark article published 52 years ago, Child and Turcotte, two surgeons who performed portacaval shunt surgery, classified patients with cirrhosis in three “functional hepatic reserve” categories: A, B, and C, corresponding to minimally, moderately, and severely altered hepatic functional reserve, respectively [1]. This classification was based on five variables, three clinical (ascites, encephalopathy, and nutritional status), and two biochemical (serum albumin and bilirubin). Notably, the selection of these variables was based on clinical experience and not on multivariable analysis, which at the time was not widely used, although they did perform actuarial survival analysis to demonstrate statistically significant differences for the probabilities of 3- and 10-year survival among the three groups. …
Literature
1.
go back to reference Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.PubMed Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.PubMed
2.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, Pietrini MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.CrossRefPubMed Pugh RN, Murray-Lyon IM, Dawson JL, Pietrini MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.CrossRefPubMed
3.
go back to reference Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, TerBorg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, TerBorg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed
4.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed
5.
go back to reference D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–354.PubMed D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–354.PubMed
6.
go back to reference Kaplan DE, Dai F, Skanderson M, et al. Recalibrating the Child–Turcotte–pugh Score to improve prediction of transplant-free survival in patients with cirrhosis. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-016-4239-6. Kaplan DE, Dai F, Skanderson M, et al. Recalibrating the Child–Turcotte–pugh Score to improve prediction of transplant-free survival in patients with cirrhosis. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-016-4239-6.
7.
go back to reference Kaplan DE, Dai F, Aytaman A, et al. Development and performance of an algorithm to estimate the Child–Turcotte–Pugh Score from a national electronic healthcare database. Clin Gastroenterol Hepatol. 2015;13:2333–2341.CrossRefPubMed Kaplan DE, Dai F, Aytaman A, et al. Development and performance of an algorithm to estimate the Child–Turcotte–Pugh Score from a national electronic healthcare database. Clin Gastroenterol Hepatol. 2015;13:2333–2341.CrossRefPubMed
8.
go back to reference Garcia-Tsao G. Natural history of cirrhosis. In: Cardenas A, Keaveny A, eds. Complications of Cirrhosis. New York: Springer; 2015. Garcia-Tsao G. Natural history of cirrhosis. In: Cardenas A, Keaveny A, eds. Complications of Cirrhosis. New York: Springer; 2015.
9.
go back to reference Zipprich A, Seufferlein T, Dollinger MM. Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis. Z Gastroenterol. 2012;50:996–1001.CrossRefPubMed Zipprich A, Seufferlein T, Dollinger MM. Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis. Z Gastroenterol. 2012;50:996–1001.CrossRefPubMed
10.
go back to reference Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.CrossRefPubMed Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.CrossRefPubMed
11.
go back to reference Ripoll C, Bari K, Garcia-Tsao G. Serum albumin can identify patients with compensated cirrhosis with a good prognosis. J Clin Gastroenterol. 2015;49:613–619.CrossRefPubMedPubMedCentral Ripoll C, Bari K, Garcia-Tsao G. Serum albumin can identify patients with compensated cirrhosis with a good prognosis. J Clin Gastroenterol. 2015;49:613–619.CrossRefPubMedPubMedCentral
12.
go back to reference Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173.CrossRefPubMed Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173.CrossRefPubMed
Metadata
Title
The Child–Turcotte Classification: From Gestalt to Sophisticated Statistics and Back
Author
Guadalupe Garcia-Tsao
Publication date
01-11-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4319-7

Other articles of this Issue 11/2016

Digestive Diseases and Sciences 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.